First National Bank & Trust Co of Newtown’s AbbVie ABBV Stock Holding History

First National Bank & Trust Co of Newtown’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37M	Sell	9,427 -230	-2%	-$49.5K	0.48%	35
2026 Q1	$2.1M	Sell	9,657 -2,109	-18%	-$468K	0.45%	40
2025 Q4	$2.69M	Buy	11,766 +239	+2%	+$54.4K	0.49%	33
2025 Q3	$2.67M	Sell	11,527 -465	-4%	-$94.7K	0.51%	31
2025 Q2	$2.23M	Sell	11,992 -130	-1%	-$24.2K	0.45%	36
2025 Q1	$2.54M	Sell	12,122 -100	-0.8%	-$19.4K	0.53%	29
2024 Q4	$2.17M	Sell	12,222 -1,550	-11%	-$285K	0.45%	33
2024 Q3	$2.72M	Hold	13,772	–	–	0.52%	31
2024 Q2	$2.36M	Sell	13,772 -943	-6%	-$156K	0.48%	31
2024 Q1	$2.68M	Sell	14,715 -140	-0.9%	-$24.1K	0.54%	29
2023 Q4	$2.3M	Sell	14,855 -250	-2%	-$36.4K	0.49%	28
2023 Q3	$2.25M	Sell	15,105 -550	-4%	-$80.7K	0.51%	28
2023 Q2	$2.11M	Sell	15,655 -215	-1%	-$31.5K	0.45%	30
2023 Q1	$2.53M	Sell	15,870 -250	-2%	-$38.2K	0.56%	25
2022 Q4	$2.61M	Hold	16,120	–	–	0.59%	26
2022 Q3	$2.16M	Hold	16,120	–	–	0.52%	28
2022 Q2	$2.47M	Sell	16,120 -45	-0.3%	-$6.88K	0.56%	27
2022 Q1	$2.62M	Sell	16,165 -350	-2%	-$50.8K	0.53%	28
2021 Q4	$2.24M	Buy	16,515 +200	+1%	+$23.6K	0.43%	35
2021 Q3	$1.76M	Buy	16,315 +50	+0.3%	+$5.71K	0.37%	41
2021 Q2	$1.83M	Buy	16,265 +10	+0.1%	+$1.13K	0.38%	40
2021 Q1	$1.76M	Sell	16,255 -1,881	-10%	-$201K	0.38%	40
2020 Q4	$1.94M	Buy	18,136 +495	+3%	+$47.6K	0.43%	35
2020 Q3	$1.54M	Buy	17,641 +1,055	+6%	+$99.3K	0.37%	39
2020 Q2	$1.63M	Buy	16,586 +467	+3%	+$41.1K	0.42%	32
2020 Q1	$1.23M	Hold	16,119	–	–	0.35%	40
2019 Q4	$1.43M	Sell	16,119 -200	-1%	-$16.6K	0.35%	42
2019 Q3	$1.24M	Hold	16,319	–	–	0.33%	48
2019 Q2	$1.19M	Sell	16,319 -300	-2%	-$23.6K	0.33%	51
2019 Q1	$1.34M	Hold	16,619	–	–	0.37%	41
2018 Q4	$1.53M	Sell	16,619 -700	-4%	-$61.6K	0.46%	34
2018 Q3	$1.64M	Sell	17,319 -365	-2%	-$34.6K	0.43%	40
2018 Q2	$1.64M	Sell	17,684 -50	-0.3%	-$4.88K	0.45%	38
2018 Q1	$1.68M	Buy	17,734 +625	+4%	+$68.7K	0.46%	37
2017 Q4	$1.66M	Sell	17,109 -700	-4%	-$66K	0.44%	39
2017 Q3	$1.58M	Sell	17,809 -460	-3%	-$35K	0.44%	37
2017 Q2	$1.32M	Hold	18,269	–	–	0.39%	42
2017 Q1	$1.19M	Hold	18,269	–	–	0.35%	46
2016 Q4	$1.14M	Hold	18,269	–	–	0.35%	43
2016 Q3	$1.15M	Hold	18,269	–	–	0.35%	45
2016 Q2	$1.15M	Sell	18,269 -500	-3%	-$30.5K	0.37%	45
2016 Q1	$1.07M	Buy	18,769 +500	+3%	+$27.9K	0.34%	47
2015 Q4	$1.08M	Buy	18,269 +500	+3%	+$28.8K	0.36%	46
2015 Q3	$967K	Hold	17,769	–	–	0.33%	50
2015 Q2	$1.19M	Hold	17,769	–	–	0.39%	42
2015 Q1	$1.04M	Sell	17,769 -250	-1%	-$15.1K	0.33%	49
2014 Q4	$1.18M	Buy	18,019 +400	+2%	+$25.2K	0.37%	46
2014 Q3	$1.02M	Hold	17,619	–	–	0.34%	47
2014 Q2	$922K	Sell	17,619 -555	-3%	-$29.1K	0.31%	49
2014 Q1	$934K	Buy	18,174 +459	+3%	+$23.2K	0.32%	49
2013 Q4	$935K	Hold	17,715	–	–	0.33%	47
2013 Q3	$793K	Buy	17,715 +600	+4%	+$26.6K	0.3%	50
2013 Q2	$707K	Buy	+17,115	New	+$749K	0.27%	52

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First National Bank & Trust Co of Newtown's ABBV Position: Q2 2026 in Review

First National Bank & Trust Co of Newtown reduced its AbbVie (ABBV) stake by 2.4% in Q2 2026, selling an estimated $49.5K and leaving 9,427 shares worth $2.37M. The position accounts for 0.48% of the portfolio, ranked #35.

First National Bank & Trust Co of Newtown first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.72M in Q3 2024. 3,435 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

First National Bank & Trust Co of Newtown held 9,427 shares of AbbVie worth $2.37M as of Q2 2026.
First National Bank & Trust Co of Newtown sold 230 AbbVie shares in Q2 2026, an estimated $49.5K.
AbbVie made up 0.48% of First National Bank & Trust Co of Newtown's portfolio in Q2 2026, its #35 holding.
First National Bank & Trust Co of Newtown first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
First National Bank & Trust Co of Newtown's AbbVie position peaked at $2.72M in Q3 2024.
3,435 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First National Bank & Trust Co of Newtown's 13F filing for Q2 2026, filed 6 Aug 2026.